Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. LOARGYS (pegzilarginase)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

LOARGYS (pegzilarginase)

Medicine - Posted on May 31 2024
Active substance (DCI)
  • pegzilarginase
history (2)
  • 5/29/24

    LOARGYS (pegzilarginase) - Arginase 1 deficiency (ARG1-D)

    Summary of opinion Favourable opinion for reimbursement in the “treatment of arginase 1 deficiency (ARG1-D), also known as h...
    CAV :
    54321
    icône flèche
  • 5/2/24

    LOARGYS (pegzilarginase) - Déficit en arginase 1

    Autorisation d’accès précoce octroyée à la spécialité LOARGYS (pegzilarginase) dans l'indication « traitement du déficit en ...
    icône flèche
Technical information
ATC code
  • A16AB24
Manufacturer
IMMEDICA PHARMA FRANCE
Presentation

LOARGYS 5 mg/ml, solution injectable/pour perfusion
1 flacon en verre de 0,4 ml (CIP : 34009 302 832 8 8)

All our publications
    Congenital, genetic and rare diseases Drug therapy Metabolic diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
6GS3m1Tu5Ch1cQrE